Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cephradine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.98 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.98 |
| ▸ | MEN1 | O00255 | 4/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.98 |
| ▸ | BLM | P54132 | 2/20 | 0.98 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.98 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | PGR | P06401 | 1/20 | 0.98 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.98 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.98 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | SLC15A2 | Q16348 | 3/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cephradine SCHEMBL28758599 | 1.00 | MAPT (0.98) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL27547040 | 1.00 | MAPT (0.98) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL719332 | 1.00 | MAPT (0.98) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL16072830 | 0.99 | MAPT (1.00) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL20969062 | 0.99 | MAPT (1.00) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL11236414 | 0.99 | MAPT (1.00) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL11236409 | 0.99 | MAPT (1.00) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL13779346 | 0.99 | MAPT (1.00) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL3244 | 0.99 | MAPT (1.00) | MAPTHSD17B10KDM4EKMT2ACYP3A4 | |
| Cephradine SCHEMBL11209915 | 0.98 | MAPT (0.98) | MAPTHSD17B10KDM4EKMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117618440-A | Application of cefradine monohydrate in preparation of cisplatin-resistant ototoxic drugs | 山东第一医科大学(山东省医学科学院) | 2024-03-01 | — | — | CN | claimed |
| EP-1641933-B1 | PROCESS FOR THE PREPARATION OF CEPHRADINE | DSM SINOCHEM PHARM NL BV (NL) | 2017-12-20 | — | — | EP | claimed |
| EP-2513327-A2 | PRODUCTION PROCESS FOR CEPHRADINE | DSM Sinochem Pharmaceuticals Netherlands B.V. (NL) | 2012-10-24 | — | — | EP | claimed |
| CN-102656274-A | Process for producing cephradine | DSM IP ASSETS BV | 2012-09-05 | — | — | CN | claimed |
| WO-2011073166-A2 | PRODUCTION PROCESS FOR CEPHRADINE | DSM IP ASSETS B.V. (NL) | 2011-06-23 | — | — | WO | claimed |
| US-7588913-B2 | Process for the preparation of cephradine | DSM IP ASSETS B.V. (NL) | 2009-09-15 | — | — | US | claimed |
| CN-100507000-C | Process for the preparation of cefradine | DSM IP ASSETS BV (NL) | 2009-07-01 | — | — | CN | claimed |
| US-20060189802-A1 | Process for the preparation of cephradine | DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) | 2006-08-24 | — | — | US | claimed |
| CN-1813069-A | Process for the preparation of cephradine | DSM IP ASSETS BV (NL) | 2006-08-02 | — | — | CN | claimed |
| EP-1641933-A2 | PROCESS FOR THE PREPARATION OF CEPHRADINE | DSM IP Assets B.V. (NL) | 2006-04-05 | — | — | EP | claimed |
| WO-2005003367-A2 | PROCESS FOR THE PREPARATION OF CEPHRADINE | DSM IP ASSETS B.V. (NL) | 2005-01-13 | — | — | WO | claimed |
| EP-0433428-B1 | A STABLE FORM OF CEPHRADINE, PROCESS FOR ITS PRODUCTION AND INTERMEDIATES USED THEREIN | BIOCHEMIE SA (ES) | 1994-10-12 | — | — | EP | claimed |
| US-5278157-A | Stable cephradine hydrate | GEMA, S.A. (ES) | 1994-01-11 | — | — | US | claimed |
| JP-8009630-B2 | — | — | 1992-02-13 | — | — | JP | claimed |
| US-5034522-A | Silating, acylation, basification and solvent extraction | BIOCRAFT LABORATORIES, INC. (US) | 1991-07-23 | — | — | US | claimed |
| EP-0433428-A1 | A STABLE FORM OF CEPHRADINE, PROCESS FOR ITS PRODUCTION AND INTERMEDIATES USED THEREIN. | GEMA SA (ES) | 1991-06-26 | — | — | EP | claimed |
| WO-1991000865-A1 | A NOVEL STABLE FORM OF CEPHRADINE, PROCESS FOR ITS PRODUCTION AND INTERMEDIATES USED THEREIN | GEMA S.A. (ES) | 1991-01-24 | — | — | WO | claimed |
| CN-119700983-A | Application of UBR5 in preparation of medicines for treating pigment dermatosis | 中南大学湘雅医院 | 2025-03-28 | — | — | CN | disclosed |
| WO-1991000865-A1 | A NOVEL STABLE FORM OF CEPHRADINE, PROCESS FOR ITS PRODUCTION AND INTERMEDIATES USED THEREIN | GEMA S.A. (ES) | 1991-01-24 | — | — | WO | disclosed |
| US-4139702-A | Process for preparing cephalosporines | DOBFAR S.P.A. (IT) | 1979-02-13 | — | — | US | disclosed |